Dawn M. Curry

A sought after speaker and mass tort lawyer, Dawn regularly publishes and speaks on panels related to product liability and white collar defense issues, as well as on e-discovery related issues.

Notable Experience and Client Impact

• Represents a variety of medical device and consumer product manufacturers in multi-district litigation (MDL) and other coordinated national litigation involving such products as metal-on-metal hip prostheses, other modular hip prostheses, and talcum powder.  Roles on the team range from serving as local counsel to leading national science teams responsible for identifying and preparing experts and developing defense strategies related to the medical, scientific and technical issues relevant to each case.
• Represented medical device manufacturer in a mass tort involving spinal implants. Managed team of associates in the review and production of over four million pages of documents.
• Represented large pharmaceutical company in a federal investigation involving allegations of off-label promotion.
• Represented hospital in responding to subpoena by OIG and USAO alleging Stark and anti-kickback violations. Successfully persuaded USAO not to bring action.
• Represented former Controller in an SEC investigation alleging backdating of stock options. SEC decided not to recommend enforcement action against our client upon completion of its investigation.
• Represented major insurance company in a trademark infringement action.

Publications

• Science Basics for the Drug and Medical Device Lawyer, DRI, authored chapter on Bradford Hill Criteria (2020).

• Product Liability: 2015 Year in Review (February 29, 2016).

• Product Liability: 2014 Year in Review (January 30, 2015).
• For the Defense publishes “What to Do When Your U.S. Mass Tort Goes International” by Dawn Curry and David Ferrera (September 2014).
• Product Liability: 2013 Year in Review (January 27, 2014).
• For the Defense publishes “Managing Physician-Company Conflict of Interest” by Dawn Curry and David Ferrera (August 23, 2011).
• New Federal Rule of Evidence 502 Seeks to Strengthen Attorney-Client Privilege and Work Product Protections (October 13, 2008).
• Co-authored They Are Coming for You: Dangers for Corporate Executives in the Expanding World of Financial Crime published by Aspatore Books (2004).
• Co-authored an article in the Boston Business Journal offering ten recommendations to safeguard directors from potential liability (2004).

Speaking Engagements

• Moderated a panel at ACI’s Fraud and Abuse in the Sale and Marketing of Drugs conference on the topic of Steering Clear of Individual Accountability: What Does Reinvigorated Enforcement Mean for Responsible Corporate Officers and Counsel?
• Presented to the Massachusetts Biotechnology Council on the topic of Document Retention and e-Discovery for Life Sciences Companies.
• Panelist at ARMA/Simmons College/Sedona Conference’s E-Discovery Overview program.
• Panelist at the Massachusetts Banking Association’s Record Retention Workshop.
• Host of a CBI webinar on the topic of Electronic Record Retention: Legal Imperatives for Biotech, Pharmaceutical & Medical Device Companies.